Hepatitis
Original Research
Antiviral Therapy Improves Hepatocellular Cancer Survival
Treatment of hepatitis C virus infection leads to overall survival benefit particularly among patients who achieve sustained virologic response...
Original Research
Comparison of Renal Function Between Tenofovir Disoproxil Fumarate and Other Nucleos(t)ide Reverse Transcriptase Inhibitors in Patients With Hepatitis B Virus Infection
A multicenter retrospective study did not find an association between tenofovir disoproxil fumarateuse and a greater degree of kidney injury...
Case Reports
Treating Hepatitis C Virus Reinfection With 8 Weeks of Ledipasvir/Sofosbuvir Achieves Sustained Virologic Response
Three patients reinfected with hepatitis C virus after a sustained virologic response were considered treatment naïve and received a short-course...
Conference Coverage
Liver transplant outcomes improving for U.S. patients with HIV/HCV
Hepatitis C virus infection no longer confers worse patient survival in the era of DAA therapy, but the population remains underserved.
Conference Coverage
HBV viremia linked to HCC risk in HIV/HBV coinfection
News
Incidence of autoimmune hepatitis may be rising
This study evaluated trends in autoimmune liver diseases over a 9-year time frame in Canterbury, New Zealand.
News
CDC: 20% of people in the U.S. are infected with an STD
News
Eliminating hepatitis by 2030: HHS releases new strategic plan
The United States “is currently facing unprecedented hepatitis A outbreaks, while progress in preventing hepatitis B has stalled, and hepatitis C...
News
Updated USPSTF HBV screening recommendation may be a ‘lost opportunity’
The recommendation defines risk groups more narrowly than the CDC, AASLD, and some research suggests risk-based screening is ineffective for...
Conference Coverage
HCC rates slow in cities, continue to climb in rural areas
Disparities in hepatocellular carcinoma incidence rates between urban and rural areas vary by race/ethnicity.